AAV Gene Therapy for Autosomal Dominant Optic Atrophy Caused by Mutation in the Opa1 Gene

被引：0
作者：
Stupay, Rachel M. [1 ]
Cascone, Alyna [1 ]
Padegimas, Linas [2 ]
Wille, Paul T. [1 ]
Kevany, Brian M. [3 ]
机构：
[1] Abeona Therapeut, Product Dev, Cleveland, OH USA
[2] Forge Biol, Grove City, OH USA
[3] Abeona Therapeut, Cleveland, OH USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1478
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [41] Contrasting pathophysiological mechanisms of OPA1 mutations in autosomal dominant optic atrophy
    Shi-Qi Yao
    Jia-Jian Liang
    Hui Zhou
    Shaoying Tan
    Yingjie Cao
    Chong-Bo Chen
    Ciyan Xu
    Ruixi Wang
    Tai-Ping Li
    Fang-Fang Zhao
    Yun Wang
    Han-Jie He
    Dan Zhang
    Meng Wang
    Lifang Liu
    Patrick Yu-Wai-Man
    Shihui Wei
    Ling-Ping Cen
    Cell Death Discovery, 11 (1)
  • [42] Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
    Almind, Gitte J.
    Gronskov, Karen
    Milea, Dan
    Larsen, Michael
    Brondum-Nielsen, Karen
    Ek, Jakob
    BMC MEDICAL GENETICS, 2011, 12
  • [43] OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina
    Pesch, UEA
    Fries, JE
    Bette, S
    Kalbacber, H
    Wissinger, B
    Alexander, C
    Kohler, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (11) : 4217 - 4225
  • [44] Dominant optic atrophy caused by a novel OPA1 mutation:: Disruption of the mitochondrial network with preserved bioenergetics
    Spinazzi, Marco
    Cazzola, Silvia
    Bortolozzi, Mario
    Baracca, Alessandra
    Loro, Emanuele
    Solaini, Giancarlo
    Sgarbi, Gianluca
    Cenacchi, Giovanna
    Malena, Adriana
    Scorrano, Luca
    Frezza, Christian
    Angelini, Corrado
    Vergani, Lodovica
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 : S56 - S56
  • [45] OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model
    Sarzi, Emmanuelle
    Seveno, Marie
    Piro-Megy, Camille
    Elziere, Lucie
    Quiles, Melanie
    Pequignot, Marie
    Mueller, Agnes
    Hamel, Christian P.
    Lenaers, Guy
    Delettre, Cecile
    SCIENTIFIC REPORTS, 2018, 8
  • [46] OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model
    Emmanuelle Sarzi
    Marie Seveno
    Camille Piro-Mégy
    Lucie Elzière
    Mélanie Quilès
    Marie Péquignot
    Agnès Müller
    Christian P. Hamel
    Guy Lenaers
    Cécile Delettre
    Scientific Reports, 8
  • [47] A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
    Mei, Shaoyi
    Huang, Xiaosheng
    Cheng, Lin
    Peng, Shiming
    Zhu, Tianhui
    Chen, Liang
    Wang, Yan
    Zhao, Jun
    JOURNAL OF OPHTHALMOLOGY, 2019, 2019
  • [48] OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy
    Tetsuya Hamahata
    Takuro Fujimaki
    Keiko Fujiki
    Ai Miyazaki
    Atsushi Mizota
    Akira Murakami
    Japanese Journal of Ophthalmology, 2012, 56 : 91 - 97
  • [49] Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy
    Nitta, Yohei
    Osaka, Jiro
    Maki, Ryuto
    Hakeda-Suzuki, Satoko
    Suzuki, Emiko
    Ueki, Satoshi
    Suzuki, Takashi
    Sugie, Atsushi
    ELIFE, 2024, 12
  • [50] OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain
    Bette, S
    Schlaszus, H
    Wissinger, B
    Meyermann, R
    Mittelbronn, M
    ACTA NEUROPATHOLOGICA, 2005, 109 (04) : 393 - 399
12345